Natrol Faces False Ad Suit Over Joint-Health Supplement

Law360, New York (October 10, 2013, 1:19 PM EDT) -- Dietary supplement maker Natrol Inc. was hit Wednesday with a proposed class action accusing it of falsely advertising that its glucosamine and chondroitin products will help joint health when actually there is no scientific evidence to back up that claim.

Plaintiff Linda Dao alleges that through a nationwide advertising campaign, Natrol advertised that Natrol GC “helps rebuild cartilage tissue” and has “clinically tested ingredients to promote optimal joint flexibility, lubrication, mobility and comfort.”

“These claimed health benefits are the only reason a consumer would purchase Natrol...
To view the full article, register now.




Case Information

Case Title

Dao v. Natrol, Inc. et al

Case Number



California Southern

Nature of Suit

Other Statutory Actions


Roger T. Benitez

Date Filed

October 9, 2013


UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.